img

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months.
Rx Irritable Bowel Syndrome (IBS) Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rx Irritable Bowel Syndrome (IBS) Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Women and Men are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rx Irritable Bowel Syndrome (IBS) Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Rx Irritable Bowel Syndrome (IBS) Drugs key companies include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals and Allergan, etc. Ironwood Pharmaceuticals, Bausch Health, Takeda are top 3 players and held % share in total in 2022.
Rx Irritable Bowel Syndrome (IBS) Drugs can be divided into IBS-D Drugs, IBS-C Drugs and Others,, etc. IBS-D Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Rx Irritable Bowel Syndrome (IBS) Drugs is widely used in various fields, such as Women and Men, etc. Women provides greatest supports to the Rx Irritable Bowel Syndrome (IBS) Drugs industry development. In 2022, global % share of Rx Irritable Bowel Syndrome (IBS) Drugs went into Women filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rx Irritable Bowel Syndrome (IBS) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
Segment by Type
IBS-D Drugs
IBS-C Drugs
Others

Segment by Application


Women
Men
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rx Irritable Bowel Syndrome (IBS) Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Rx Irritable Bowel Syndrome (IBS) Drugs introduction, etc. Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Rx Irritable Bowel Syndrome (IBS) Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Rx Irritable Bowel Syndrome (IBS) Drugs
1.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Overview
1.1.1 Rx Irritable Bowel Syndrome (IBS) Drugs Product Scope
1.1.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Status and Outlook
1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2034)
1.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Region (2024-2024)
1.5 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034)
1.6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034)
1.6.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034)
1.6.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034)
1.6.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034)
1.6.5 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034)
2 Rx Irritable Bowel Syndrome (IBS) Drugs Market by Type
2.1 Introduction
2.1.1 IBS-D Drugs
2.1.2 IBS-C Drugs
2.1.3 Others
2.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2024-2024)
2.2.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Type (2024-2034)
3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Overview by Application
3.1 Introduction
3.1.1 Women
3.1.2 Men
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2024-2024)
3.2.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Breakdown by Application (2024-2034)
4 Rx Irritable Bowel Syndrome (IBS) Drugs Competition Analysis by Players
4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2022)
4.3 Date of Key Players Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
4.4 Global Top Players Rx Irritable Bowel Syndrome (IBS) Drugs Headquarters and Area Served
4.5 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ironwood Pharmaceuticals
5.1.1 Ironwood Pharmaceuticals Profile
5.1.2 Ironwood Pharmaceuticals Main Business
5.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
5.1.4 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$ Million) & (2024-2024)
5.1.5 Ironwood Pharmaceuticals Recent Developments
5.2 Bausch Health
5.2.1 Bausch Health Profile
5.2.2 Bausch Health Main Business
5.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
5.2.4 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$ Million) & (2024-2024)
5.2.5 Bausch Health Recent Developments
5.3 Takeda
5.3.1 Takeda Profile
5.3.2 Takeda Main Business
5.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
5.3.4 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$ Million) & (2024-2024)
5.3.5 Sebela Pharmaceuticals Recent Developments
5.4 Sebela Pharmaceuticals
5.4.1 Sebela Pharmaceuticals Profile
5.4.2 Sebela Pharmaceuticals Main Business
5.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
5.4.4 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$ Million) & (2024-2024)
5.4.5 Sebela Pharmaceuticals Recent Developments
5.5 Allergan
5.5.1 Allergan Profile
5.5.2 Allergan Main Business
5.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
5.5.4 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$ Million) & (2024-2024)
5.5.5 Allergan Recent Developments
6 North America
6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Rx Irritable Bowel Syndrome (IBS) Drugs Market Dynamics
11.1 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends
11.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
11.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
11.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Region (2024-2024)
Table 4. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2024)
Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Table 11. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2024)
Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2022)
Table 39. Date of Key Players Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
Table 40. Global Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Headquarters and Area Served
Table 41. Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
Table 42. Global Rx Irritable Bowel Syndrome (IBS) Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Ironwood Pharmaceuticals Basic Information List
Table 45. Ironwood Pharmaceuticals Description and Business Overview
Table 46. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Rx Irritable Bowel Syndrome (IBS) Drugs Business of Ironwood Pharmaceuticals (2024-2024)
Table 48. Ironwood Pharmaceuticals Recent Developments
Table 49. Bausch Health Basic Information List
Table 50. Bausch Health Description and Business Overview
Table 51. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Rx Irritable Bowel Syndrome (IBS) Drugs Business of Bausch Health (2024-2024)
Table 53. Bausch Health Recent Developments
Table 54. Takeda Basic Information List
Table 55. Takeda Description and Business Overview
Table 56. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Rx Irritable Bowel Syndrome (IBS) Drugs Business of Takeda (2024-2024)
Table 58. Takeda Recent Developments
Table 59. Sebela Pharmaceuticals Basic Information List
Table 60. Sebela Pharmaceuticals Description and Business Overview
Table 61. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Rx Irritable Bowel Syndrome (IBS) Drugs Business of Sebela Pharmaceuticals (2024-2024)
Table 63. Sebela Pharmaceuticals Recent Developments
Table 64. Allergan Basic Information List
Table 65. Allergan Description and Business Overview
Table 66. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Rx Irritable Bowel Syndrome (IBS) Drugs Business of Allergan (2024-2024)
Table 68. Allergan Recent Developments
Table 69. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 70. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 71. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 72. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 73. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 75. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 76. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2024-2024)
Table 77. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2024-2034)
Table 78. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 80. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 81. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 82. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 83. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 84. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
Table 85. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
Table 86. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
Table 87. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions: 2022 VS 2034
Figure 4. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of IBS-D Drugs
Figure 11. Global IBS-D Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of IBS-C Drugs
Figure 13. Global IBS-C Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Type: 2022 & 2034
Figure 17. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Figure 18. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Figure 22. Women Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Men Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application: 2022 & 2034
Figure 25. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Figure 26. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Figure 30. Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share in 2022
Figure 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2024-2034)
Figure 33. U.S. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 36. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2024-2034)
Figure 42. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 46. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2024-2034)
Figure 49. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2024-2034)
Figure 52. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries